On August 19, a recent SEC filing unveiled that Michael Petras Jr, Executive Chairman at Sotera Health (NASDAQ:SHC) made an insider sell.

What Happened: Jr's recent Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday unveiled the sale of 1,144,515 shares of Sotera Health. The total transaction value is $21,174,786.

Tracking the Thursday's morning session, Sotera Health shares are trading at $19.0, showing a up of 1.13%.

Get to Know Sotera Health Better

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

Financial Insights: Sotera Health

Revenue Growth: Sotera Health displayed positive results in 3 months. As of 30 June, 2026, the company achieved a solid revenue growth rate of approximately 9.18%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

Profitability Metrics: Unlocking Value

• Gross Margin: Achieving a high gross margin of 55.38%, the company performs well in terms of cost management and profitability within its sector.
• Earnings per Share (EPS): Sotera Health's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.19.

Debt Management: Sotera Health's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 3.41.

Valuation Metrics:

• Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 33.33, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
• Price to Sales (P/S) Ratio: The Price to Sales ratio is 4.51, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
• EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): With an EV/EBITDA ratio lower than industry averages at 13.77, Sotera Health could be considered undervalued.

Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.

Why Insider Transactions Are Important

Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.

When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company’s equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.

A new purchase by a company insider is a indication that they anticipate the stock will rise.

On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.

Exploring Key Transaction Codes

Delving into transactions, investors typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.

Check Out The Full List Of Sotera Health's Insider Trades.

This article was generated by Benzinga's automated content engine and reviewed by an editor.